Plasma Fraction Market Key Players and Growth Insights

Top Companies in the Plasma Fraction Market

1. Baxter International
   Baxter International is a global healthcare company that specializes in the development and production of plasma-based therapies, including treatments for hemophilia, immune deficiencies, and other conditions requiring plasma-derived therapies. Their products are sold worldwide, catering to diverse medical needs.
2. Bayer
   Bayer is a multinational pharmaceutical and life sciences company that produces plasma-derived products as part of its extensive healthcare portfolio. Bayer’s offerings focus on treating rare diseases and chronic conditions using plasma fractionation technology.
3. Biotest
   Biotest is a global biotech company focused on the development, production, and commercialization of plasma-based therapeutics. It specializes in immunology, hematology, and intensive care medicine, offering a wide range of plasma-derived products.
4. BPL (Bio Products Laboratory)
   BPL is a leading provider of plasma-derived therapies, specializing in the treatment of rare and chronic diseases, including hemophilia and immune deficiencies. The company is renowned for its commitment to high-quality products and innovation in the plasma fraction market.
5. CBPO (China Biologic Products, Inc.)
   CBPO is a major player in the plasma fraction market, known for its production of high-quality human plasma-derived products. It provides treatments for immune deficiencies, bleeding disorders, and other therapeutic areas in China and globally.
6. CSL Behring
   CSL Behring, a division of CSL Limited, is a global leader in the development and production of human plasma-based therapies. The company focuses on a range of conditions such as hemophilia, immune deficiencies, and bleeding disorders, providing life-saving treatments worldwide.
7. Fusion Healthcare
   Fusion Healthcare develops and manufactures plasma-derived therapies, focusing on providing advanced medical treatments to address immunological and hematological disorders. The company is known for its high-quality products and global reach.
8. Grifols
   Grifols is a Spanish multinational corporation that specializes in the development of plasma-derived medicines. It is one of the largest players in the plasma fraction market, offering therapies for diseases such as hemophilia, immune deficiencies, and other chronic conditions.
9. Kedrion Biopharma Inc.
   Kedrion Biopharma is a global biopharmaceutical company that focuses on the development, production, and distribution of plasma-derived therapies. Their product portfolio includes treatments for bleeding disorders and immune deficiencies, contributing to the advancement of plasma fractionation.
10. KM Biologics
    KM Biologics, part of the Japan-based KM Group, focuses on producing plasma-derived medicines, including immunoglobulins and coagulation factors. The company is dedicated to expanding its presence in the global plasma fraction market.
11. LBF USA
    LBF USA is a key player in the plasma fraction market, specializing in the development and distribution of plasma-derived products. Their offerings are critical for the treatment of a wide range of diseases, especially those related to immune and bleeding disorders.
12. LFB Group
    LFB Group is a French biotechnology company that develops and manufactures plasma-derived therapeutics. The company’s products treat various health conditions, including hemophilia, immune deficiencies, and other serious illnesses.
13. Nanyue Bio
    Nanyue Bio is a leading Chinese biopharmaceutical company that focuses on the production of plasma-derived products. Their range of therapies addresses conditions such as immune deficiencies and bleeding disorders, contributing to the advancement of the global plasma fraction market.
14. Octopharma
    Octopharma is a Swiss-based company specializing in the development of human plasma-derived therapies. Their product range includes immunoglobulins, clotting factors, and albumin, offering life-saving treatments for a variety of diseases worldwide.
15. RAAS (Rafael Advanced Defense Systems)
    RAAS is involved in the plasma fraction market with a focus on producing high-quality plasma-derived treatments. Their products are essential for treating chronic and rare diseases, especially those related to bleeding and immune deficiencies.
16. Takeda Pharmaceuticals
    Takeda Pharmaceuticals is a global biopharmaceutical company that produces a broad range of plasma-derived therapies. The company’s portfolio includes treatments for hemophilia, immune system disorders, and other plasma-related diseases, expanding its footprint in the global market.
17. Tiantan Bio
    Tiantan Bio is a Chinese biopharmaceutical company known for producing plasma-derived products for the treatment of chronic diseases. The company is expanding its global presence with a focus on quality and innovation in plasma fractionation.
18. Weiguang Bio
    Weiguang Bio is a Chinese biotechnology company that focuses on plasma fractionation and the development of plasma-derived therapies. Their products serve critical therapeutic needs in immunology and hematology, playing a significant role in the plasma fraction market.